Cargando…

Recent advances and emerging therapies in the non-surgical management of ulcerative colitis

The so-called “biologicals” (monoclonal antibodies to various inflammatory targets like tumor necrosis factor or integrins) have revolutionized the treatment of inflammatory bowel diseases. In ulcerative colitis, they have an established role in inducing remission in steroid-refractory disease and,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehkamp, Jan, Stange, Eduard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081982/
https://www.ncbi.nlm.nih.gov/pubmed/30135722
http://dx.doi.org/10.12688/f1000research.15159.1

Ejemplares similares